A Single Oral Dose Study Of PF-06409577 In Healthy Adult Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
PF-06409577 is a new compound proposed for the treatment of diabetic nephropathy. The primary purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of single oral doses of PF-06409577 in healthy adult subjects.
Epistemonikos ID: a995e1d93d8cf8868edff7d692ac53569892ead2
First added on: May 12, 2024